LBEL CLARITE Clarifying Effect Foundation SPF 30CLAIRE 1- BEIGE (Ventura Corporation LTD)
Welcome to the PulseAid listing for the LBEL CLARITE Clarifying Effect Foundation SPF 30 drug offered from Ventura Corporation LTD. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ventura Corporation LTD |
| NON-PROPRIETARY NAME: | Octinoxate, Oxybenzone, and Zinc Oxide |
| SUBSTANCE NAME: | OCTINOXATE; OXYBENZONE; ZINC OXIDE |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | SUSPENSION |
| MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
| START MARKETING DATE: | 2016-06-06 |
| END MARKETING DATE: | 0000-00-00 |
LBEL CLARITE Clarifying Effect Foundation SPF 30 CLAIRE 1- BEIGE HUMAN OTC DRUG Details:
| Item Description | LBEL CLARITE Clarifying Effect Foundation SPF 30 CLAIRE 1- BEIGE from Ventura Corporation LTD |
| LABELER NAME: | Ventura Corporation LTD |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | .075; .02; .0196(g/g; g/g; g/g) |
| START MARKETING DATE: | 2016-06-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 13537-943_9b314ad0-a338-4616-99c3-25f0f38d608b |
| PRODUCT NDC: | 13537-943 |
| APPLICATION NUMBER: | part352 |
Other OCTINOXATE; OXYBENZONE; ZINC OXIDE Pharmaceutical Manufacturers / Labelers:
